MarketWatch: Asia shares were off by 2%. Reuters: Riots against austerity measures continued n Greece. Reuters: US regulators want to increase supervision of broadband. Reuters: The Fed’s Rosengren says rates must stay…
Reuters: Google Inc.’s (NASDAQ: GOOG) password operation was hit by cyberattacks. Reuters: A leading political party in Germany is urging that the nation not deal with Goldman Sachs Group (NYSE: GS). Reuters: …
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have developed and marketed most…
The IPO market is off to a rough start so far in 2010. We have seen very recent developments in deals on deck to price from CBOE Holdings Inc., Convio Inc., Everyday Health Inc.,…
Reuters: Novartis (NYSE:NVS) will buy the part of Alcon (NYSE:ACL) that it does not currently own for $39 billion. Reuters: JAL may receive a bailout from the Japanese government. Reuters: The Fed defended it…
Markets in Asia were narrowly mixed. The Nikkei rose 1.1% to 10,865. JAL rose on news of government financial support. The Hang Seng fell .2% to 21,823. The Shanghai Composite dropped 1%…
Douglas A. McIntyre Reuters: Ken Lewis will step down as CEO of Bank of America (BAC) Reuters: Cisco (CSCO) bought Tandbeg for $3 billion. Reuters: The IMF raised forecasts for US GDP but warned on…
These are this Tuesday morning’s top analyst upgrades and positive research calls that we have seen from Wall Street research with about two hours until the market opens: ArcelorMittal (MT) Raised to…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
There were many analyst calls this morning, but the problem is that most were on smaller companies or were by second and third tier boutiques. These were the top call from Wall…
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s osteoporosis drug…
These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours volume activity with links to more detailed price and volume analysis on…
Reuters: GM will accept product liability on cars it has built in the past. Reuters: Obama could consider a second stimulus if necessary. Reuters: Rising office availability in NYC is slowing. Reuters: …
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones,…
These are not all of the upgrades and positive analyst calls on Wall Street this morning, but these are the ones we are focusing on early this Tuesday morning: Annaly Capital (NLY)…
